Isoquercitrin alleviates lipopolysaccharide-induced intestinal mucosal barrier damage in mice by regulating TLR4/MyD88/NF-κB signaling pathway and intestinal flora DOI

Enhui Tang,

Tong Hu,

Zhaokang Jiang

et al.

Food & Function, Journal Year: 2023, Volume and Issue: 15(1), P. 295 - 309

Published: Dec. 6, 2023

Isoquercitrin alleviates lipopolysaccharide-induced intestinal mucosal barrier damage in mice.

Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses DOI Creative Commons

Sonakshi Rastogi,

Aditi Singh

Frontiers in Pharmacology, Journal Year: 2022, Volume and Issue: 13

Published: Oct. 24, 2022

The highest density of microbes resides in human gastrointestinal tract, known as “Gut microbiome”. Of note, the members genus Lactobacillus that belong to phyla Firmicutes are most important probiotic bacteria gut microbiome. These gut-residing species not only communicate with each other but also epithelial lining balance barrier integrity, mucosal defence and ameliorate host immune responses. body suffers from several inflammatory diseases affecting gut, lungs, heart, bone or neural tissues. Mounting evidence supports significant role spp. their components (such metabolites, peptidoglycans, and/or surface proteins) modulatingimmune responses, primarily through exchange immunological signals between tract distant organs. This bidirectional crosstalk which is mediated by promotes anti-inflammatory response, thereby supporting improvement symptoms pertaining asthma, chronic obstructive pulmonary disease (COPD), neuroinflammatory multiple sclerosis, alzheimer’s disease, parkinson’s disease), cardiovascular diseases, bowel (IBD) infections patients. metabolic disorders, obesity diabetes characterized a low-grade inflammation. Genus alleviates disorders regulating oxidative stress response pathways. Osteoporosis associated inflammation resorption. metabolites act powerful cell controllers exhibit regulatory resorption formation, health. Thus, this review demonstrated mechanisms summarized benefit alleviating different organs animal clinical trials. present narrative explores detail complex interactions gut-dwelling promote host’s

Language: Английский

Citations

141

Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease DOI Open Access

Yoonhwa Shin,

Sunhee Han,

Juhui Kwon

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(20), P. 4466 - 4466

Published: Oct. 21, 2023

The gut microbiome is a diverse bacterial community in the human gastrointestinal tract that plays important roles variety of biological processes. Short-chain fatty acids (SCFA) are produced through fermentation dietary fiber. Certain microbes responsible for producing SCFAs such as acetate, propionate and butyrate. An imbalance diversity can lead to metabolic disorders inflammation-related diseases. Changes SCFA levels associated microbiota were observed IBD, suggesting an association between disease. affect reactive oxygen species (ROS) with IBD. Gut closely related it study them further.

Language: Английский

Citations

76

Probiotics and Food Bioactives: Unraveling Their Impact on Gut Microbiome, Inflammation, and Metabolic Health DOI
Alice Njolke Mafe, Great Iruoghene Edo, Patrick Othuke Akpoghelie

et al.

Probiotics and Antimicrobial Proteins, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 14, 2025

Language: Английский

Citations

10

Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects DOI
Bushra Bashir, Monica Gulati, Sukriti Vishwas

et al.

Ageing Research Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 102689 - 102689

Published: Feb. 1, 2025

Language: Английский

Citations

3

The role of the gut microbiota in health and cardiovascular diseases DOI Creative Commons
Lu Wang, Shiqi Wang, Qing Zhang

et al.

Molecular Biomedicine, Journal Year: 2022, Volume and Issue: 3(1)

Published: Oct. 11, 2022

Abstract The gut microbiota is critical to human health, such as digesting nutrients, forming the intestinal epithelial barrier, regulating immune function, producing vitamins and hormones, metabolites interact with host. Meanwhile, increasing evidence indicates that has a strong correlation occurrence, progression treatment of cardiovascular diseases (CVDs). In patients CVDs corresponding risk factors, composition ratio have significant differences compared their healthy counterparts. Therefore, dysbiosis, microbiota-generated metabolites, related signaling pathway may serve explanations for some mechanisms about occurrence development CVDs. Several studies also demonstrated many traditional latest therapeutic treatments are associated its generated pathways. Given information, we summarized advances in current research regarding effect on main CVDs, highlighted roles several introduced promising microbiota. this review mainly focuses exploring role potential which eventually provide better solutions well prevention

Language: Английский

Citations

70

Unlocking a novel determinant of athletic performance: The role of the gut microbiota, short-chain fatty acids, and “biotics” in exercise DOI Creative Commons
Kate M. Sales, Raylene A. Reimer

Journal of sport and health science/Journal of Sport and Health Science, Journal Year: 2022, Volume and Issue: 12(1), P. 36 - 44

Published: Sept. 9, 2022

The gut microbiota refers to the collection of trillions intestinal microorganisms that modulate central aspects health and disease through influential effects on host physiology. Recently, a connection has been made between exercise. Initial investigations demonstrated beneficial exercise microbiota, with cross-sectional studies revealing positive correlations exercise-associated states, healthy interventions showed post-intervention increases in abundance bacterial taxa. More recent have focused exploring reverse relationship: influence performance. Murine revealed certain taxa may enhance endurance performance by augmenting various lactate metabolism. Further, short-chain fatty acids-which metabolism at organ sites, including within skeletal muscle-have shown capacity mice. This review highlights what is currently known about exercise, particular focus ergogenic potential how it be leveraged

Language: Английский

Citations

42

Probiotics and Postbiotics as the Functional Food Components Affecting the Immune Response DOI Creative Commons
Aleksandra Szydłowska, Barbara Sionek

Microorganisms, Journal Year: 2022, Volume and Issue: 11(1), P. 104 - 104

Published: Dec. 31, 2022

The food market is one of the most innovative segments world economy. Recently, among consumers there a forming trend healthier lifestyle and interest in functional foods. Products with positive health properties are good source nutrients for consumers' nutritional needs reduce risk metabolic diseases such as diabetes, atherosclerosis, or obesity. They also seem to boost immune system. One types "probiotic products", which contain viable microorganisms beneficial properties. However, due some technical difficulties their development marketing, new alternative has started be sought. Many scientific studies point possibility effects on human health, so-called "postbiotics", characteristic metabolites microbiome. Both immunobiotics post-immunobiotics components that affect response two ways: inhibition (suppressing allergies inflammation) an enhancement (providing host defenses against infection). This work's aim was conduct literature review possibilities using probiotics postbiotics affecting response, emphasis recently published works.

Language: Английский

Citations

39

Postbiotics as Molecules Targeting Cellular Events of Aging Brain—The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases DOI Open Access

Pola Głowacka,

Katarzyna Oszajca, Agnieszka Pudlarz

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(14), P. 2244 - 2244

Published: July 12, 2024

Aging is the most prominent risk factor for neurodegeneration occurrence. The common neurodegenerative diseases (NDs), Alzheimer’s (AD) and Parkinson’s (PD) diseases, are characterized by incidence of proteinopathy, abnormal activation glial cells, oxidative stress, neuroinflammation, impaired autophagy cellular senescence excessive patient’s age. Moreover, mitochondrial disfunction, epigenetic alterations neurogenesis inhibition, together with increased blood–brain barrier permeability gut dysbiosis, have been linked to ND pathogenesis. Since NDs still lack curative treatment, recent research has sought therapeutic options in restoring microbiota supplementing probiotic bacteria-derived metabolites beneficial action host—so called postbiotics. current review focuses on literature explaining mechanisms involved pathogenesis addressing impact that postbiotics as a whole mixture particular metabolites, such short-chain fatty acids (SCFAs), lactate, polyamines, polyphenols, tryptophan exopolysaccharides bacterial extracellular vesicles, ageing-associated processes underlying also discusses issue implementing into prophylaxis therapy, depicting them compounds senescence-triggered dysfunctions worth translating from bench pharmaceutical market response “silver consumers” demands.

Language: Английский

Citations

9

Appraising the role of biotics and fermented foods in gut microbiota modulation and sleep regulation DOI Open Access
Akanksha Singh, Pradeep Singh Negi

Journal of Food Science, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 3, 2025

Abstract Sleep disturbances are increasingly prevalent, significantly impacting physical and mental health. Recent research reveals a bidirectional relationship between gut microbiota sleep, mediated through the microbiota–gut–brain axis. This review examines role of in sleep physiology explores how biotics, including probiotics, prebiotics, synbiotics, postbiotics, fermented foods, can enhance quality. Drawing from animal human studies, we discuss neurobiological mechanisms by which biotics may influence modulation neurotransmitters, immune responses, hormonal regulation. Key microbial metabolites, such as short‐chain fatty acids, highlighted for their supporting sleep‐related neurochemical processes. Additionally, this presents dietary strategies food processing technologies, like fermentation, innovative approaches enhancement. Although promising, available has limitations, small sample sizes, variability biotic strains dosages, reliance on subjective assessments. underscores need standardized protocols, objective assessments polysomnography, personalized interventions. Emerging findings highlight therapeutic potential improvement, though further large‐scale trials essential to refine strain selection, dosage, formulation. interdisciplinary exploration seeks advance food‐based interventions holistic managing disorders improving quality life.

Language: Английский

Citations

1

Gut microbiome as a therapeutic target for liver diseases DOI
Tejinder Pal Singh, Saurabh Kadyan,

Harisha Devi

et al.

Life Sciences, Journal Year: 2023, Volume and Issue: 322, P. 121685 - 121685

Published: April 10, 2023

Language: Английский

Citations

20